03/15/2024
3:45 PM | Bone Biologics (Filer)
Bone Biologics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/14/2024
4:10 PM | Bone Biologics (Subject)
Bone Biologics Corp (Subject)
INTRACOASTAL CAPITAL, LLC (Filed by)
| Form SC 13G | |
03/06/2024
3:20 PM | Bone Biologics (Filer)
Bone Biologics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2024
11:15 PM | Bone Biologics (Filer)
Bone Biologics Corp (Filer)
| Form EFFECT | |
03/01/2024
7:05 AM | Bone Biologics (Filer)
Bone Biologics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
5:41 PM | Bone Biologics (Subject)
Bone Biologics Corp (Subject)
Ionic Ventures, LLC (Filed by)
| Form SC 13G/A | |
02/14/2024
9:55 AM | Bone Biologics (Subject)
Bone Biologics Corp (Subject)
Walleye Capital LLC (Filed by)
| Form SC 13G/A | |
|
02/13/2024
7:03 PM | Bone Biologics (Subject)
Bone Biologics Corp (Subject)
Lind Global Fund II LP (Filed by)
| Form SC 13G/A | |
01/24/2024
11:15 PM | Bone Biologics (Filer)
Bone Biologics Corp (Filer)
| Form EFFECT | |
01/19/2024
4:24 PM | Bone Biologics (Issuer)
Bone Biologics Corp (Issuer)
Walsh Deina H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
4:22 PM | Bone Biologics (Issuer)
Bone Biologics Corp (Issuer)
Frelick Jeff (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:21 PM | Bone Biologics (Filer)
Bone Biologics Corp (Filer)
| Form S-3/A | |
01/12/2024
4:15 PM | Bone Biologics (Filer)
Bone Biologics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/11/2024
7:15 AM | Bone Biologics (Filer)
Bone Biologics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2024
4:15 PM | Bone Biologics (Issuer)
Bone Biologics Corp (Issuer)
Gagnon Robert E. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/10/2024
4:17 PM | Bone Biologics (Issuer)
Bone Biologics Corp (Issuer)
Gagnon Robert E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
7:15 AM | Bone Biologics (Filer)
Bone Biologics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
4:15 PM | Bone Biologics (Filer)
Bone Biologics Corp (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/02/2024
4:15 PM | Bone Biologics (Filer)
Bone Biologics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2024
2:34 PM | Bone Biologics (Subject)
Bone Biologics Corp (Subject)
SABBY MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
12/20/2023
4:21 PM | Bone Biologics (Subject)
Bone Biologics Corp (Subject)
Ionic Ventures, LLC (Filed by)
| Form SC 13G/A | |
12/18/2023
7:05 AM | Bone Biologics (Filer)
Bone Biologics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2023
8:15 AM | Bone Biologics (Filer)
Bone Biologics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/29/2023
11:26 AM | Bone Biologics (Filer)
Bone Biologics Corp (Filer)
| Form D
Notice of Exempt Offering of Securities | |
11/27/2023
5:10 AM | Bone Biologics (Subject)
Bone Biologics Corp (Subject)
INTRACOASTAL CAPITAL, LLC (Filed by)
| Form SC 13G | |
11/20/2023
6:44 AM | Bone Biologics (Filer)
Bone Biologics Corp (Filer)
| Form 424B5 | |
11/20/2023
6:46 AM | Bone Biologics (Filer)
Bone Biologics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2023
6:00 AM | Bone Biologics (Filer)
Bone Biologics Corp (Filer)
| Form DEF 14A | |
11/20/2023
5:50 AM | Bone Biologics (Filer)
Bone Biologics Corp (Filer)
| Form 10-K/A | |
11/14/2023
3:05 PM | Bone Biologics (Filer)
Bone Biologics Corp (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/09/2023
3:51 PM | Bone Biologics (Filer)
Bone Biologics Corp (Filer)
| Form PRE 14A | |
10/24/2023
5:06 AM | Bone Biologics (Filer)
Bone Biologics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/29/2023
4:19 PM | Bone Biologics (Filer)
Bone Biologics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2023
1:54 PM | Bone Biologics (Issuer)
Bone Biologics Corp (Issuer)
Stroever Bruce (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2023
1:54 PM | Angle Siddhesh Rajendra (Reporting)
Bone Biologics (Issuer)
Bone Biologics Corp (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2023
1:54 PM | Bone Biologics (Issuer)
Bone Biologics Corp (Issuer)
Lucera Erick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/15/2023
3:48 PM | Bone Biologics (Filer)
Bone Biologics Corp (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
09/14/2023
10:08 AM | Bone Biologics (Issuer)
Bone Biologics Corp (Issuer)
Walsh Deina H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2023
3:01 PM | Bone Biologics (Filer)
Bone Biologics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2023
10:34 AM | Bone Biologics (Issuer)
Bone Biologics Corp (Issuer)
Frelick Jeff (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/07/2023
9:45 AM | Bone Biologics (Issuer)
Bone Biologics Corp (Issuer)
Walsh Deina H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Tech GIANT’s Plans to Revolutionize Crypto… (Ad) A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products.
If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE…
The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
 Claim your free seat by clicking here now. |
08/14/2023
2:17 PM | Bone Biologics (Filer)
Bone Biologics Corp (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/03/2023
5:25 AM | Bone Biologics (Filer)
Bone Biologics Corp (Filer)
| Form ARS | |
08/03/2023
5:15 AM | Bone Biologics (Filer)
Bone Biologics Corp (Filer)
| Form DEF 14A | |
08/03/2023
5:20 AM | Bone Biologics (Filer)
Bone Biologics Corp (Filer)
| Form DEFA14A | |
07/05/2023
3:41 PM | Bone Biologics (Filer)
Bone Biologics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2023
3:50 PM | Bone Biologics (Subject)
Bone Biologics Corp (Subject)
Lind Global Fund II LP (Filed by)
| Form SC 13G | |
06/16/2023
1:53 PM | Bone Biologics (Filer)
Bone Biologics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/15/2023
7:25 PM | Bone Biologics (Filer)
Bone Biologics Corp (Filer)
| Form 424B4 | |
06/14/2023
11:15 PM | Bone Biologics (Filer)
Bone Biologics Corp (Filer)
| Form EFFECT | |
06/13/2023
5:04 AM | Bone Biologics (Filer)
Bone Biologics Corp (Filer)
| Form S-1/A | |
06/06/2023
4:19 PM | Bone Biologics (Filer)
Bone Biologics Corp (Filer)
| Form S-1/A | |
06/06/2023
12:14 PM | Bone Biologics (Filer)
Bone Biologics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/11/2023
11:57 AM | Bone Biologics (Filer)
Bone Biologics Corp (Filer)
| Form DEF 14C | |
